Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Subodh Verma

Showing results (551-560 of 616) with videos related to

Pageof 62
Sort By:
JACC. Heart Failure|August 9, 2023
Effect of Sotagliflozin on Early Mortality and Heart Failure-Related Events: A Post Hoc Analysis of SOLOIST-WHFBertram Pitt, Deepak L Bhatt, Michael Szarek, et al.
JAMA|March 28, 2026
Evolocumab to Reduce First Major Cardiovascular Events in Patients Without Known Significant Atherosclerosis and With Diabetes: Results From the VESALIUS-CV TrialNicholas A Marston, Erin A Bohula, Ajay K Bhatia, et al.
The Journal of Thoracic and Cardiovascular Surgery|July 18, 2018
The American Association for Thoracic Surgery consensus guidelines on bicuspid aortic valve-related aortopathy: Executive summaryMichael A Borger, Paul W M Fedak, Elizabeth H Stephens, et al.
Diabetes, Obesity & Metabolism|November 8, 2021
Restrictive versus liberal transfusion in patients with diabetes undergoing cardiac surgery: An open-label, randomized, blinded outcome evaluation trialNikhil Mistry, Nadine Shehata, Paula Carmona, et al.
JACC. Heart Failure|December 31, 2021
Efficacy of Dapagliflozin in Black Versus White Patients With Heart Failure and Reduced Ejection FractionKieran F Docherty, Modele O Ogunniyi, Inder S Anand, et al.
Iscience|August 14, 2023
Methemoglobin as a marker of acute anemic stress in cardiac surgeryNikhil Mistry, Gregory M T Hare, Nadine Shehata, et al.
The New England Journal of Medicine|November 13, 2018
Low-Dose Methotrexate for the Prevention of Atherosclerotic EventsPaul M Ridker, Brendan M Everett, Aruna Pradhan, et al.
JAMA Cardiology|November 3, 2022
Dapagliflozin and Kidney Outcomes in Patients With Heart Failure With Mildly Reduced or Preserved Ejection Fraction: A Prespecified Analysis of the DELIVER Randomized Clinical TrialFinnian R Mc Causland, Brian L Claggett, Muthiah Vaduganathan, et al.
Journal of the American College of Cardiology|September 1, 2024
Effect of Semaglutide on Cardiac Structure and Function in Patients With Obesity-Related Heart FailureScott D Solomon, John W Ostrominski, Xiaowen Wang, et al.
The Canadian Journal of Cardiology|February 25, 2018
2018 Canadian Cardiovascular Society/Canadian Association of Interventional Cardiology Focused Update of the Guidelines for the Use of Antiplatelet TherapyShamir R Mehta, Kevin R Bainey, Warren J Cantor, et al.
Pageof 62

Showing results (551-560 of 616) with videos related to

Sort By:
Pageof 62
JACC. Heart Failure|August 9, 2023
Effect of Sotagliflozin on Early Mortality and Heart Failure-Related Events: A Post Hoc Analysis of SOLOIST-WHFBertram Pitt, Deepak L Bhatt, Michael Szarek, et al.
JAMA|March 28, 2026
Evolocumab to Reduce First Major Cardiovascular Events in Patients Without Known Significant Atherosclerosis and With Diabetes: Results From the VESALIUS-CV TrialNicholas A Marston, Erin A Bohula, Ajay K Bhatia, et al.
The Journal of Thoracic and Cardiovascular Surgery|July 18, 2018
The American Association for Thoracic Surgery consensus guidelines on bicuspid aortic valve-related aortopathy: Executive summaryMichael A Borger, Paul W M Fedak, Elizabeth H Stephens, et al.
Diabetes, Obesity & Metabolism|November 8, 2021
Restrictive versus liberal transfusion in patients with diabetes undergoing cardiac surgery: An open-label, randomized, blinded outcome evaluation trialNikhil Mistry, Nadine Shehata, Paula Carmona, et al.
JACC. Heart Failure|December 31, 2021
Efficacy of Dapagliflozin in Black Versus White Patients With Heart Failure and Reduced Ejection FractionKieran F Docherty, Modele O Ogunniyi, Inder S Anand, et al.
Iscience|August 14, 2023
Methemoglobin as a marker of acute anemic stress in cardiac surgeryNikhil Mistry, Gregory M T Hare, Nadine Shehata, et al.
The New England Journal of Medicine|November 13, 2018
Low-Dose Methotrexate for the Prevention of Atherosclerotic EventsPaul M Ridker, Brendan M Everett, Aruna Pradhan, et al.
JAMA Cardiology|November 3, 2022
Dapagliflozin and Kidney Outcomes in Patients With Heart Failure With Mildly Reduced or Preserved Ejection Fraction: A Prespecified Analysis of the DELIVER Randomized Clinical TrialFinnian R Mc Causland, Brian L Claggett, Muthiah Vaduganathan, et al.
Journal of the American College of Cardiology|September 1, 2024
Effect of Semaglutide on Cardiac Structure and Function in Patients With Obesity-Related Heart FailureScott D Solomon, John W Ostrominski, Xiaowen Wang, et al.
The Canadian Journal of Cardiology|February 25, 2018
2018 Canadian Cardiovascular Society/Canadian Association of Interventional Cardiology Focused Update of the Guidelines for the Use of Antiplatelet TherapyShamir R Mehta, Kevin R Bainey, Warren J Cantor, et al.
Pageof 62